Karen Zaghiyan, MD
Surgery · West Hollywood, CANPI 1508191214
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (43.1%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Intuitive Surgical at 41.3% of the total. Reporting peaked in 2021 at $11,556 and has fallen 96.1% since, to $455 in 2025.
Across 148 payments — averaging $159.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$10K
- Prescient Surgical$6K
- Takeda Pharmaceuticals U.S.A., Inc.$4K
- Medtronic$2K
- Activ Surgical, Inc.$500
- Vioptix Inc$207
- plus $1K from 23 others
Across 7 payments — averaging $23,097 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Reddress LTD$159K
- Takeda Pharmaceuticals U.S.A., Inc.$3K
What the payments were for
- Consulting fees$10,18643%
- Speaking & faculty fees$7,35031%
- Travel & lodging$1,1585%
- Food & beverage$4,80020%
- Education$1261%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 21 | $9,760 |
| Prescient Surgical | 7 | $5,879 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $4,264 |
| Medtronic(2 entities) | 73 | $1,673 |
| Activ Surgical, Inc. | 1 | $500 |
| Vioptix Inc | 3 | $207 |
| Acelrx Pharmaceuticals, Inc. | 2 | $148 |
| Integra Lifesciences Corporation | 4 | $147 |
| Davol Inc. | 3 | $145 |
| Nevro Corp. | 1 | $123 |
| Vertex | 4 | $109 |
| Axonics, Inc. | 3 | $108 |
| Conmed Corporation | 1 | $77 |
| Acell, Inc. | 3 | $56 |
| Baxter Healthcare | 1 | $54 |
| AstraZeneca | 2 | $47 |
| Ferring Pharmaceuticals Inc. | 1 | $42 |
| AbbVie | 1 | $34 |
| Biotissue Holdings Inc. | 1 | $29 |
| Innovation Technologies Inc | 1 | $26 |
| Kowa Pharmaceuticals America, Inc. | 1 | $25 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $24 |
| Boston Scientific | 1 | $23 |
| Aroa Biosurgery Incorporated | 1 | $23 |
| Shire North American Group Inc | 1 | $21 |
| Teleflex LLC | 1 | $21 |
| Johnson & Johnson | 1 | $20 |
| Cook Medical LLC | 1 | $18 |
| Merck | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$9,241
- CleanCision$5,857
- ActivSight$500
- INTERSTIM$498
- EEA$183
- DSUVIA$123
- Senza Spinal Cord Stimulation System$123
- T. Ox Tissue Oximeter$106
How this compares
$23,620 in reported general payments places this provider in the 85th percentile of 2,363 surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgery in West Hollywood
- Daniel ShouhedWest Hollywood$214K
- Timothy ChuterSan Francisco$8.8M
- Santiago HorganSan Diego$2.8M
- Rock LiuHayward$1.6M
- David LouriePasadena$1.4M
- Andrea PakulaThousand Oaks$1.4M
- Siew-Ming LeeFresno$1.3M
- Beemen KhalilPalo Alto$1.1M
- John LiphamLos Angeles$942K
- Alexander NedopilLodi$682K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.